Article 06 Jul 2016 Once Again, Retained Rights In Federally Funded, Patented Drugs Will Not Be Asserted To Control Price United States Healthcare
Article 16 May 2016 Coordinating Your Reimbursement And Regulatory Strategies For A Successful Product Launch United States Healthcare
Article 01 Apr 2016 What You Need To Know About Retained Rights In Federally Funded Patented Drugs United States Healthcare
Article 05 Oct 2015 Many Questions For, But Not Many Answers From, The FDA On Biosimilars Implementation After Congressional Hearing United States Healthcare
Article 02 Oct 2015 Many Questions For, But Not Many Answers From, The FDA On Biosimilars Implementation After Last Week's Hearing United States Healthcare
Article 03 Aug 2015 Identifying The Likely Beneficiaries Of An Emerging Biosimilars Market United States Healthcare
Article 28 Jul 2015 For Biosimilars In The US, Interchangeability With The Innovator Reference Product Is The Goal, But There Is Still Much Work To Be Done United States Healthcare